{"id":"https://openalex.org/W2017333581","doi":"https://doi.org/10.1182/blood-2009-07-233304","title":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1","display_name":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1","publication_year":2010,"publication_date":"2010-03-03","ids":{"openalex":"https://openalex.org/W2017333581","doi":"https://doi.org/10.1182/blood-2009-07-233304","mag":"2017333581","pmid":"https://pubmed.ncbi.nlm.nih.gov/20197552","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858493"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2009-07-233304","doi":"https://doi.org/10.1182/blood-2009-07-233304","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2009-07-233304","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858493","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031944813","display_name":"Derek William Yecies","orcid":"https://orcid.org/0000-0001-8534-4651","observed_orcids":["https://orcid.org/0000-0001-8534-4651"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Derek Yecies","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","Department of Medical Oncology, Dana-Farber Cancer Institute Boston MA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute Boston MA USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055076896","display_name":"Nicole E. Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicole E. Carlson","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065668271","display_name":"Jing Deng","orcid":"https://orcid.org/0000-0003-3157-5723","observed_orcids":["https://orcid.org/0000-0003-3157-5723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jing Deng","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031944813","https://openalex.org/A5055076896","https://openalex.org/A5065668271"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":12.1061,"has_fulltext":false,"cited_by_count":371,"citation_normalized_percentile":{"value":0.99376689,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"115","issue":"16","first_page":"3304","last_page":"3313"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abt-737","display_name":"ABT-737","score":0.9909999966621399},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7350000143051147},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8859999775886536},{"id":"https://openalex.org/keywords/bfl-1","display_name":"Bfl-1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.7689999938011169},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7129999995231628},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5230000019073486},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.7820000052452087},{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/transcriptional-upregulation","display_name":"transcriptional upregulation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/mitochondrial-targeting","display_name":"mitochondrial targeting","score":0.3790000081062317},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.5662436485290527},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5382921695709229},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5341666340827942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48286062479019165},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4685909152030945},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4469633102416992},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.43555495142936707},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4024950861930847},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3326719403266907},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32917606830596924},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22858083248138428},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20319288969039917},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16893112659454346},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.1087522804737091}],"mesh":[{"descriptor_ui":"D000072224","descriptor_name":"Bcl-2-Like Protein 11","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009596","descriptor_name":"Nitrophenols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015778","descriptor_name":"Minor Histocompatibility Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047468","descriptor_name":"Immunoprecipitation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051023","descriptor_name":"BH3 Interacting Domain Death Agonist Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/blood-2009-07-233304","doi":"https://doi.org/10.1182/blood-2009-07-233304","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2009-07-233304","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2088932","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858493","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2858493","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858493","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},{"id":"pmid:20197552","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20197552","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.608.6850","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.608.6850","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://research.dfci.harvard.edu/letai/papers/Yecies.BLOOD.2010.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2088932","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2858493","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1067474891","display_name":null,"funder_award_id":"K08 CA10254","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6346896279","display_name":"Probing mitochondria and personalizing leukemia therapy with BH3 profiling","funder_award_id":"R01CA129974","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1519177607","https://openalex.org/W1527712367","https://openalex.org/W1607777232","https://openalex.org/W1913661233","https://openalex.org/W1943486034","https://openalex.org/W1971234510","https://openalex.org/W1976720365","https://openalex.org/W1994068418","https://openalex.org/W1994740077","https://openalex.org/W1995775226","https://openalex.org/W1999197294","https://openalex.org/W2004388628","https://openalex.org/W2008841394","https://openalex.org/W2008898220","https://openalex.org/W2009183764","https://openalex.org/W2016575124","https://openalex.org/W2017898416","https://openalex.org/W2021658758","https://openalex.org/W2021844011","https://openalex.org/W2027395744","https://openalex.org/W2032049833","https://openalex.org/W2066408263","https://openalex.org/W2068606395","https://openalex.org/W2068962767","https://openalex.org/W2074978329","https://openalex.org/W2081567150","https://openalex.org/W2081857093","https://openalex.org/W2085419794","https://openalex.org/W2097007474","https://openalex.org/W2097290512","https://openalex.org/W2107020701","https://openalex.org/W2116177527","https://openalex.org/W2118691390","https://openalex.org/W2125499510","https://openalex.org/W2135080095","https://openalex.org/W2152247516","https://openalex.org/W2152876030","https://openalex.org/W2162747336","https://openalex.org/W2165208382","https://openalex.org/W2166467949","https://openalex.org/W2167690894","https://openalex.org/W2168632005","https://openalex.org/W2968333193","https://openalex.org/W6640560003","https://openalex.org/W6676103088"],"related_works":["https://openalex.org/W7097058147","https://openalex.org/W2118863989","https://openalex.org/W1994740077","https://openalex.org/W7027431648","https://openalex.org/W2980690798","https://openalex.org/W2027395744","https://openalex.org/W2021658758","https://openalex.org/W2075188262","https://openalex.org/W2153571329","https://openalex.org/W2046279786"],"abstract_inverted_index":{"ABT-737":[0,96,128,166],"is":[1],"a":[2,160,184],"small-molecule":[3],"antagonist":[4],"of":[5,17,35,67,78,189],"BCL-2":[6,94],"currently":[7],"under":[8],"evaluation":[9],"in":[10,13,58,97,104,145,150,155,173],"clinical":[11],"trials":[12],"the":[14,59,68,111],"oral":[15],"form":[16],"ABT-263.":[18],"We":[19],"anticipate":[20],"that":[21],"acquired":[22],"resistance":[23,36],"to":[24,37,64,70,127,147],"this":[25],"promising":[26],"drug":[27,69],"will":[28],"inevitably":[29],"arise.":[30],"To":[31],"study":[32],"potential":[33],"mechanisms":[34],"ABT-737,":[38],"we":[39],"derived":[40],"resistant":[41,101,105,129,156,174],"lines":[42,51],"from":[43,93],"initially":[44],"sensitive":[45],"OCI-Ly1":[46],"and":[47,61,100,153,170],"SU-DHL-4":[48],"lymphoma":[49],"cell":[50],"via":[52],"long-term":[53],"exposure.":[54],"Resistance":[55],"was":[56,91,108,132,159],"based":[57],"mitochondria":[60],"not":[62,85,134],"due":[63],"an":[65],"inability":[66],"bind":[71],"BCL-2.":[72],"Resistant":[73],"cells":[74,175],"had":[75],"increased":[76,141],"levels":[77,118,172],"BFL-1":[79,113,168],"and/or":[80,114],"MCL-1":[81,117,131,151],"proteins,":[82],"which":[83],"are":[84],"targeted":[86],"by":[87,95,110,135,140],"ABT-737.":[88],"Proapoptotic":[89],"BIM":[90,107],"displaced":[92],"both":[98],"parental":[99],"cells,":[102,106,157],"but":[103,138],"sequestered":[109],"additional":[112],"MCL-1.":[115],"Decreasing":[116],"with":[119,194],"flavopiridol,":[120],"PHA":[121],"767491,":[122],"or":[123],"shRNA":[124],"restored":[125],"sensitivity":[126],"cells.":[130],"up-regulated":[133],"protein":[136,154,169,191],"stabilization":[137],"rather":[139],"transcript":[142,152,171],"levels.":[143],"Surprisingly,":[144],"addition":[146],"stable":[148],"increases":[149],"there":[158],"dynamic":[161,181],"increase":[162,182],"within":[163],"hours":[164],"after":[165],"treatment.":[167],"were":[176],"similarly":[177],"dynamically":[178],"up-regulated.":[179],"This":[180],"suggests":[183],"novel":[185],"mechanism":[186],"whereby":[187],"modulation":[188],"antiapoptotic":[190],"function":[192],"communicates":[193],"nuclear":[195],"transcriptional":[196],"machinery.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":24},{"year":2018,"cited_by_count":21},{"year":2017,"cited_by_count":27},{"year":2016,"cited_by_count":31},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":35},{"year":2013,"cited_by_count":37},{"year":2012,"cited_by_count":36}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}